Editorial: Paraganglioma - All in the family

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 790-792

  Young Jr , William F ^a,c   Abboud, Abbie L ^b  

^a MAYO CLINIC   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL MEDULLA; CATECHOLAMINE RELEASE; CHROMOSOME 1Q; CLINICAL FEATURE; EDITORIAL; FAMILIAL DISEASE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENOTYPE; HUMAN; MALIGNANT TRANSFORMATION; PARAGANGLIOMA; PARAGANGLION; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RARE DISEASE; RISK ASSESSMENT; SDHB GENE; SDHC GENE; SDHD GENE; VON HIPPEL LINDAU DISEASE;

FEMALE; HUMANS; IRON-SULFUR PROTEINS; MALE; MEMBRANE PROTEINS; MUTATION; PARAGANGLIOMA; PROTEIN SUBUNITS; SUCCINATE DEHYDROGENASE;

EID: 33644824458     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2758     Document Type: Editorial

References (16)

1. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard III CW, Cornelisse CJ, Devilee P, Devlin B 2000 Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848-851
2. Bayley JP, Devilee P, Taschner PE 2005 The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 6:39
3. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young Jr WF 2001 Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86:5210-5216
4. Lloyd RV, Tischer AS, Kimura N, McNicol AM, Young Jr WF 2004 Adrenal tumors: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. Lyon, France: International Agency for Research on Cancer; 136-138
5. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C, Freiburg-Warsaw-Columbus Pheochromocytoma Study Group 2002 Germ-line mutations in nonsyndromeic pheochromocytoma. N Engl J Med 346:1459-1466
6. Gimm O, Koch CA, Januszewicz A, Opocher G, Neumann HP 2004 The genetic basis of pheochromocytoma. Front Horm Res 31:45-60
7. Elder EE, Elder G, Larsson C 2005 Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89:193-201
8. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, Ploos van Amstel HK, Lips CJ, Nishisho I, Takai S-I, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Hendy GN, Gharib H, Thibodeau SN, Lacroix A, Frilling A, Ponder BAJ, Mulligan LM 1996 The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575-1579
9. Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB 2003 Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg 138:409-416
10. Astuti D, Douglas F, Lennard TWJ, Aligianis IA, Woodward ER, Evans DG, Eng C, Latif F, Maher ER 2001 Germline SDHD mutation in familial phaeochromocytoma. Lancet 357:1181-1182
11. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C, European-American Paraganglioma Study Group 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-951
12. Young AL, Baysal BE, Deb A, Young Jr WF 2002 Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab 87:4101-4105
13. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, Jeunemaitre X, COMETE Network 2003 Mutations in SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 63:5615-5621
14. Schiavi F, Boedeker CC, Bausch B, Peczkowska M, Gomez CF, Strassburg T, Pawlu C, Buchta M, Salzmann M, Hoffmann MM, Berlis A, Brink I, Cybulla M, Muresan M, Walter MA, Forrer F, Valimaki M, Kawecki A, Szutkowski Z, Schipper J, Walz MK, Pigny P, Bauters C, Willet-Brozick JE, Baysal BE, Januszewicz A, Eng C, Opocher G, Neumann HP, European-American Paraganglioma Study Group 2005 Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294:2057-2063
15. McWhinney SR, Pilarski RT, Forrester SR, Schneider MC, Sarquis MM, Dias EP, Eng C 2004 Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J Clin Endocrinol Metab 89:5694-5699
16. Benn DE, Gimenez-Roqueplo A-P, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PLM, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin P-F, Robinson BG, for the International SDH Consortium 2006 Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 91:827-836